HomeTrialNCT05387980
🔬NCT05387980ACTIVE NOT RECRUITING

A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.

Study Summary

The purpose of this study is to learn about the safety and effectiveness (how well the study treatment works) of the study medicine (CIBINQO) for the potential treatment of atopic dermatitis in people under Japanese medical practice.

Interventions / Drugs
View on ClinicalTrials.gov ↗
Study Details
Enrollment1128 participants
Primary Completion
Lead SponsorPfizer
Data Retrieved2026-04-11 02:55:53.190530+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.